home / stock / pali / pali quote
Last: | $6.46 |
---|---|
Change Percent: | 1.41% |
Open: | $6.29 |
Close: | $6.46 |
High: | $6.46 |
Low: | $5.95 |
Volume: | 29,459 |
Last Trade Date Time: | 05/16/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$6.46 | $6.29 | $6.46 | $6.46 | $5.95 | 29,459 | 05-16-2024 |
$6.38 | $6.23 | $6.38 | $6.6499 | $6.1 | 37,807 | 05-15-2024 |
$6.24 | $6 | $6.24 | $6.39 | $5.86 | 65,425 | 05-14-2024 |
$6.22 | $6.71 | $6.22 | $6.71 | $6 | 22,304 | 05-13-2024 |
$6.71 | $6.8 | $6.71 | $6.8999 | $6.6801 | 12,654 | 05-10-2024 |
$6.94 | $6.98 | $6.94 | $7.039 | $6.6151 | 34,444 | 05-09-2024 |
$7.06 | $7.54 | $7.06 | $7.73 | $6.6706 | 80,719 | 05-08-2024 |
$7.9 | $8.35 | $7.9 | $8.57 | $7.85 | 64,938 | 05-07-2024 |
$8.46 | $7.41 | $8.46 | $8.56 | $7.41 | 212,870 | 05-06-2024 |
$7.74 | $7.12 | $7.74 | $7.9 | $6.9601 | 162,296 | 05-03-2024 |
$7.29 | $6.63 | $7.29 | $7.6699 | $6.6169 | 302,817 | 05-02-2024 |
$7.08 | $7.95 | $7.08 | $9.09 | $6.36 | 12,245,497 | 05-01-2024 |
$6.03 | $5.94 | $6.03 | $6.31 | $5.81 | 55,697 | 04-30-2024 |
$6.18 | $5.94 | $6.18 | $6.5 | $5.81 | 217,895 | 04-29-2024 |
$6.05 | $5.98 | $6.05 | $6.5 | $5.76 | 266,852 | 04-26-2024 |
$6.23 | $6.1 | $6.23 | $6.4 | $5.72 | 73,511 | 04-25-2024 |
$6.35 | $5.69 | $6.35 | $6.45 | $5.51 | 457,607 | 04-24-2024 |
$5.92 | $6.87 | $5.92 | $8.17 | $5.67 | 23,342,393 | 04-23-2024 |
$4.93 | $4.66 | $4.93 | $5 | $4.66 | 29,825 | 04-22-2024 |
$4.71 | $4.68 | $4.71 | $5.07 | $4.5 | 145,573 | 04-19-2024 |
News, Short Squeeze, Breakout and More Instantly...
Palisade Bio Inc. Company Name:
PALI Stock Symbol:
NASDAQ Market:
– Company on track to commence Phase 1 human clinical study of lead product candidate, PALI-2108, for the treatment of Ulcerative Colitis (UC) before year end – Sufficient cash on hand to execute on business plan and reach clinical and regulatory milestones into 2025 ...
Jet.AI Inc. (JTAI) is expected to report for Q1 2024 Forian Inc. (FORA) is expected to report $-0.02 for Q1 2024 Square Enix Holdings Co. Ltd (SQNXF) is expected to report for Q4 2024 Qutoutiao Inc. (QTT) is expected to report for Q4 2023 Molecular Partners AG (MOLN) is expected t...
Wall Street and biotech industry veteran with expertise across corporate finance, business development, M&A, licensing, and strategic alliance transactions, globally Carlsbad, CA, May 07, 2024 (GLOBE NEWSWIRE) -- Palisade Bio, Inc. (Nasdaq: PALI) (“Palisadeȁ...